key: cord-0947030-ie2wambj authors: Bouchara, Jean-Philippe; Chotirmall, Sanjay H.; Hagen, Ferry; Chaturvedi, Vishnu title: Mycopathologia 2020: Legacy and Change to Remain Relevant for Content, Creation, and Communication date: 2021-03-11 journal: Mycopathologia DOI: 10.1007/s11046-021-00531-7 sha: 749d42728b05449233f14ca54c4e0cd98f7cf0e1 doc_id: 947030 cord_uid: ie2wambj The 2020 COVID-19 pandemic had a profound impact on the publishing landscape. The ‘pre-peer-review’ publication model is likely to become common as a lag in publishing is not acceptable in a pandemic or other time! Mycopathologia is well placed to adopt such changes with its improved editorial processes, article formats, author engagements, and published articles’ access and citation. Mycopathologia had an improved journal impact factor and article downloads in 2018–2019. A limited sampling suggested a slight decrease in the total submissions in 2019 (352 articles) compared to 2018 (371 articles). However, the acceptance rate improved to 30% in 2019 from 19% in 2018. Nearly half of all submissions in 2019 were rejected before peer-review or transferred to other Springer Nature journals. The published articles were contributed from 34 different countries, with authors from China, the USA, and Brazil among the top three contributors. An enhanced editorial oversight allowed peer-reviewers to focus on fewer articles that were well-matched to their expertise, which led to lower rejection rates post-peer-review. The introduction of MycopathologiaGENOME and MycopathologiaIMAGE article types received a good reception with notable downloads and citations. The 2020 COVID-19 pandemic had devastating effects on science, society, and the planet [1] . The unprecedented upheavals have not receded yet, but the good news about the vaccines is providing the first sign of hope for 2021. COVID-19 caused sudden, unplanned, and prolonged interruption in the scientific enterprise. However, out of urgency and necessity, scientists, physicians, and public health professionals made major scientific advances on COVID-19 and SARS-CoV-2. They shared the progress at record speed via the pre-print deposits [2] [3] [4] . The 'pre-peerreview' explosion in scientific literature has changed the publishing landscape. There is near consensus about its overall benefits with scope for self-correction or peer-reviewed correction as follow-up steps [5] [6] [7] . The SARS-CoV-2 and COVID-19 pre-print publications are continuing to appear at a staggering pace, which leads to the need for new platforms to keep up with the aggregation and analysis challenges [8] . The much-debated and sometimes doubted future of the peer-reviewed scientific journal remains strong even after this pandemic experience [9, 10] . The immediate lesson for us in Mycopathologia is to explore options to present pre-peer-review versions of the manuscript because a lag in publishing is not acceptable in a pandemic or other time! We are working on implementing pre-peer-review articles on the Mycopathologia/Springer Nature website soon. This write-up also presents an update on the journal's status since we made notable changes on the occasion of the eightieth anniversary of Mycopathologia [11] . We detail progress in editorial processes, article formats, author engagements, and published articles' access and citation. Mycopathologia had an improved journal impact factor (JIF) in 2018-2019. Like other scientists, we do not consider JIF to be an accurate indicator of a journal's quality and especially, the quality of the individual articles published in Mycopathologia. We would also want to restrain ourselves from any activity that gives the impression of gaming this flawed ranking system [12] [13] [14] ! However, our authors and readers have little choice but to depend upon this single metric to assure the quality of the peer-review they receive and the likely future impact of their work [15, 16] . JIF's role has become too important for decisions concerning academic careers and rewards thereof [17] . While great minds work to improve or replace the JIF, we hope that Mycopathologia will continue to have relevant JIF vis-a-vis peer journals to continue to attract valued authors and readers from our target community [18] . We summarize in Fig. 1 the overall copy flow and editorial outcomes for the manuscripts submitted in 2018-2019. There was a slight decrease in the total submission in 2019 (352articles) compared to 2018 (371 articles). However, the acceptance rate improved to 30% in 2019 from 19% in 2018. A clue to this difference lies in the way we handled the rejections in the two years. Nearly half of all submissions in 2019 were rejected before the peer-review or transferred to other Springer Nature journals. Only 10% of 2018 articles received editorial rejection without peerreview, and we transferred a majority to other journals. The enhanced editorial oversight at the beginning of the submission improved our decision process to match an article to the scope and priority of Mycopathologia. This editorial practice also provided an expedited decision for the authors. Last, our valued peer-reviewers had more time to devote to fewer articles that were well-matched to their expertise, which possibly kept the rejection rates low after completing the peer-review. Our esteemed peerreviewers have remained pivotal to the mission of Mycopathologia, and we humbly acknowledged their academic service in the last issue of 2020. We restricted analysis of the articles to mid-2018-2019, as we only introduced changes at the end of 2018 [11, 19] . We only used a limited set of these publications to derive several helpful observations without inflating self-citations. From this limited analysis, we find most published manuscripts are categorized as original papers, while reviews and editorials make up less than 10% of published articles (Fig. 2) . The published articles were contributed from 34 different countries, with authors from China (26 articles), the USA (17 articles), and Brazil (16 articles) among the top three contributors. We introduced two new Mycopathologia article types in 2018-2019. MycopathologiaGENOME provided a succinct description of newly characterized fungal genomes in a peer-reviewed format [20] . As the publication of the case reports is scrutinized among biomedical journals, we kept this article type with restrictions and introduced a new format, Myco-pathologiaIMAGE article type [19] . It appears both article types have received a good reception in a short period. They have high downloads at the Springer Nature website and gaining citations in different databases (Table 1) . We list the articles with the highest Scopus and Google Scholar citations in Table 2 . The highest article citations skew towards reviews and editorials. Curiously, we found that most downloaded articles were a different mix to the highest cited ones with few overlaps (Table 3 )! Please note the lists in Tables 1-3 are not entirely mutually exclusive despite introducing new article formats recently. Along with similar trends, we also found twenty-five articles in the sample set were not yet cited in the databases but were still attracting downloads. The highest was 243, and the lowest downloads for an article being 126 (Table 4 ). This very selective and incomplete bibliometric analysis has few lessons: Where do we go with these lessons? We will introduce best practices identified by our peers in the publishing world. We will expand coverage and collaborate with colleagues, especially from countries not on the map in this overview. Besides pre-peer review, we will work to publish peer reviews alongside each published article in Mycopathologia. We will ensure a reasonable turnover of the manuscript from submission to decision. We will become more active on social media, hoping that our readers have not reached digital fatigue yet! 16 21 Isavuconazole in a successful combination treatment of disseminated mucormycosis in a child with acute lymphoblastic leukaemia and generalized haemochromatosis: A case report and review of the literature The high-quality complete genome sequence of the opportunistic fungal pathogen Candida vulturna CBS 14366T 1194 2 2 Naming the coronavirus disease (COVID-19) and the virus that causes it. Geneva: World Health Organization Peer review: publishing in the time of COVID-19 Surging publications on the COVID-19 pandemic Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility. The Lancet Global Health From amazing work to I beg to differ-analysis of bioRxiv preprints that received one public comment till Preprints and scholarly communication: an exploratory qualitative study of adoption, practices, drivers and barriers COVIDScholar: an automated COVID-19 research aggregation and analysis platform Scientific authors in a changing world of scholarly communication: what does the future hold? Medical and scientific publishing: author, editor, and reviewer perspectives Eighty years of Mycopathologia: a retrospective analysis of progress made in understanding human and animal fungal pathogens Citation metrics for appraising scientists: misuse, gaming and proper use Gaming the metrics: Misconduct and manipulation in academic research You are what you read: bias, journal prestige and manipulation. Arch Dis Child Educ Pract Factors affecting journal submission numbers: Impact factor and peer review reputation Factors influencing researchers' journal selection decisions Meta-research: use of the journal impact factor in academic review, promotion, and tenure evaluations Rethinking impact factors: better ways to judge a journal The curious case of ''Case Report'' of infections caused by human and animal fungal pathogens: an educational tool, an online archive, or a format in need of retooling Myco-pathologiaGENOMES: the new 'Home' for the publication of fungal genomes Attack, defend and persist: how the fungal pathogen Candida auris was able to emerge globally in healthcare environments Talaromycosis (Penicilliosis) due to Talaromyces (Penicillium) marneffei: Insights into the clinical trends of a major fungal disease 60 years after the dscovery of the pathogen Culture supernatants of Lactobacillus gasseri and L. crispatus inhibit Candida albicans biofilm formation and adhesion to HeLa cells Infections caused by Fusarium species in pediatric cancer patients and review of published literature Antifungal activity of chitosan-coated poly(lactic-co-glycolic) acid nanoparticles containing amphotericin B. Mycopathologia TR34/L98H mutation in CYP51A gene in Aspergillus fumigatus cinical isolates during posaconazole prophylaxis: first case in Korea Isavuconazole in a successful combination treatment of disseminated mucormycosis in a child with acute lymphoblastic leukaemia and generalized haemochromatosis: a case report and review of the literature Candidemia in adults at a tertiary hospital in China: clinical characteristics, species distribution, resistance, and outcomes Invasive pulmonary aspergillosis complicated by carbapenem-resistant Pseudomonas aeruginosa infection during pembrolizumab immunotherapy for metastatic lung adenocarcinoma: case report and review of the literature The authors are Executive editors (JPB, FH, SHC) and Editorin-Chief (VC) of Mycopathologia. Acknowledgements We thank Mycopathologia publishing editor Dr. Claudia Panuschka for valuable insights, analysis, and helpful critique of this editorial.